| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/28/2009 | CN101352505A Bone fracture setting medicine powder for treating traumatic injury |
| 01/28/2009 | CN101352503A Plaster for treating joint ache and preparation method thereof |
| 01/28/2009 | CN101352501A Chinese medicine for treating traumatic injury and production method |
| 01/28/2009 | CN101352482A Use of salvia root and ginseng preparation in preventing and treating senile osteoporosis |
| 01/28/2009 | CN101352480A Chinese medicinal composition for treating osteoporosis and preparation method thereof |
| 01/28/2009 | CN101352398A Method for preparing non-water hand cleanser |
| 01/28/2009 | CN100455671C Method for biologic preparing 4, 4 dihydric bowel lactone from burdock glycoside |
| 01/28/2009 | CN100455568C 6-position substituted indoline, production and use thereof as medicament |
| 01/28/2009 | CN100455301C Therapeutical use of sophora flavescens or sophora subprostrated extracts |
| 01/28/2009 | CN100455280C An externally applied ointment |
| 01/27/2009 | US7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482436 Human antihuman interleukin-6 antibody and fragment of antibody |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482362 Substituted-4-quinolones |
| 01/27/2009 | US7482357 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 01/27/2009 | US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482026 Compositions and methods directed towards sore muscles and joints |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482000 Point mutations; immunology |
| 01/27/2009 | CA2489407C Lasofoxifene tablet and its coating |
| 01/27/2009 | CA2418167C Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
| 01/27/2009 | CA2395226C Devices for the delivery of drugs having antiprogestinic properties |
| 01/27/2009 | CA2378803C Vitamin d3 analogs |
| 01/27/2009 | CA2361605C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2173846C Cntf family antagonists |
| 01/22/2009 | WO2009012425A2 Compositions including leukotriene antagonists and nsaids and methods of using the same |
| 01/22/2009 | WO2009010707A1 Injectable pharmaceutical compositions containing panthenol |
| 01/22/2009 | WO2009010491A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use |
| 01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 01/22/2009 | WO2008109177A3 Metalloprotease inhibitors containing a heterocyclic moiety |
| 01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | US20090023900 Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same |
| 01/22/2009 | US20090023795 Kinase Inhibitors And Methods Of Use Thereof |
| 01/22/2009 | US20090023788 Treatment of CRTH2-mediated diseases and conditions |
| 01/22/2009 | US20090023774 Pyridine analogs as C5A antagonists |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023761 Heterocyclic compounds and their uses |
| 01/22/2009 | US20090023748 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023747 Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023742 Thiazolones for use as pi3 kinase inhibitors |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023732 Citrate Salt of an Indole Derivative and its Pharmaceutical Use |
| 01/22/2009 | US20090023731 Soluble epoxide hydrolase inhibitors |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023661 Use of Antagonists of the Bradykinin B2 Receptor for the Treatment of Osteoarthrosis |
| 01/22/2009 | US20090023652 Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
| 01/22/2009 | US20090023646 GHRH analogues |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023147 Diagnostics and therapeutics for osteoporosis |
| 01/22/2009 | US20090022832 Method of treating inflammation disorders using extracts of passion fruit |
| 01/22/2009 | US20090022816 Storable, consumable pre-nascent iodine |
| 01/22/2009 | US20090022811 Mineralized guided bone regeneration membranes and methods of making the same |
| 01/22/2009 | US20090022773 Porous and biocompatible carrier material for treating bone and/or cartilage defects |
| 01/22/2009 | US20090022771 Biomaterial |
| 01/22/2009 | US20090022770 Chitosan Compositions |
| 01/22/2009 | US20090022731 Arthritis-associated B cell gene expression |
| 01/22/2009 | US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022717 Antibodies that bind cxcr7 epitopes |
| 01/22/2009 | US20090022698 Composition For Treatment Of Articular Cartilage Damage |
| 01/22/2009 | US20090022669 Compositions for protein delivery via the pulmonary route |
| 01/22/2009 | CA2696833A1 Disease treatment via antimicrobial peptides or their inhibitors |
| 01/22/2009 | CA2693887A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/21/2009 | EP2017266A1 Pyridazine derivatives and medicines containing the same as effective ingredients |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
| 01/21/2009 | EP2015769A2 Pharmaceutical compositions of hglp-1, exendin-4 and analogs thereof |
| 01/21/2009 | EP1863792B1 Atp competitive kinase inhibitors |
| 01/21/2009 | EP1506228B1 Role of p62 in aging-related disease |
| 01/21/2009 | EP1499610B1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP1301192B1 Use of polysulphated cyclodextrins for treating osteoarthritis |
| 01/21/2009 | CN101351453A 杂环酰胺化合物及其用途 The heterocyclic amide compounds and use thereof |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347606A Chinese medicine plaster for treating rheumatism osteonosus |
| 01/21/2009 | CN101347605A Chinese medicinal composition for treating gout and preparation method and application thereof |
| 01/21/2009 | CN101347598A Liniment spray for bonesetting and pain-alleviating |
| 01/21/2009 | CN101347582A Chinese medicinal composition for dispelling wind and freeing collateral vessels, strengthening muscles and bones, and preparation method thereof |
| 01/21/2009 | CN101347577A Medicated wine for treating rheumatalgia |
| 01/21/2009 | CN101347568A Formulation of yam pills and quality control method |
| 01/21/2009 | CN101347558A Chinese medicine for treating rheumatism osteonosus |
| 01/21/2009 | CN101347551A Chinese medicine composition for treating internal medicine symptoms of bone fracture |
| 01/21/2009 | CN101347539A Medicament for treating ache of joint and preparation thereof |
| 01/21/2009 | CN101347515A Quick-acting antalgic plaster for detoxication and detumescence |
| 01/21/2009 | CN101347507A Medicament composition for treating traumatology disease and preparation, use, medicinal preparation and quality control method thereof |
| 01/21/2009 | CN101347487A Chinese medicine external-use decoction for dispelling wind |
| 01/21/2009 | CN101347477A Medicament composition for treating rheumatoid arthritis |
| 01/21/2009 | CN101347469A Composition containing extracts of Butyrospermum parkii and the use as medicament or dietary supplement |